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INTRODUCTION
Our society is increasingly becoming more dependent on medi-
cation.1 This is an issue that concerns all members of our society from
people older than sixty using cholesterol-lowering drugs, to people in
between twenty and fifty-nine using an antidepressant, to younger
people prescribed attention deficit hyperactivity disorder medication.2
Although this is an important social and legal issue concerning all
demographic groups, this Note will focus on foster children and the
effects of overprescription of psychotropic drugs.
Overprescribing psychotropic drugs to foster children is a signifi-
cant problem. This type of medication is prescribed to foster children
at high rates relative to the rest of the population.3 There are some
statistics that suggest fifty percent of children in foster care could be
“prescribed one or more psychotropic medications.” 4
There are two main reasons that the overprescription of psycho-
tropic drugs should aggrieve society’s morals and sensibilities. First,
1. Nicholas Bakalar, Prescription Drug Use Soared in Past Decade, N.Y. TIMES
(Oct. 18, 2010), http://www.nytimes.com/2010/10/19/health/research/19stats.html?_r=0.
2. Id.
3. A. Rachel Camp, A Mistreated Epidemic: State and Federal Failure to Adequately
Regulate Psychotropic Medications Prescribed to Children in Foster Care, 83 TEMP. L. REV.
369, 373 (2011).
4. Id.
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foster children are some of the most vulnerable members of our soci-
ety. These children do not have a stable home life, and in many cases
they are shuffled around to different foster homes.5 This can create a
situation where these children do not have a benefactor invested in
their future.6
Second, the very nature of psychotropic drugs can create a noxious
effect on children. These drugs change the brain chemistry and thus
alter cognition.7 Our cognition and mental faculties are what make us
who we are; when people think about an individual, usually his or her
personality is the first thing that comes to mind.8 By prescribing these
types of drugs to a child, his or her very essence is being altered, and
the freedom of his or her individuality and creative thinking is being
stifled.9 Many of these children do not have strong parental advice
or oversight to make a decision on whether to medicate.10 Also, the
children do not have the capacity to make this important and life-
altering decision.11
These two reasons, the vulnerability of foster children and the
nature of psychotropic drugs, will provide the foundation for the pol-
icy argument below that the federal and state governments should
reform the system concerning prescribing these types of drugs to
foster children.
The federal government has passed statutes mandating states to
create oversight committees and mechanism for medical care, and psy-
chotropic drugs for foster children specifically.12 However, as stated
above, this does not go far enough. This Note proposes that the federal
government and the individual states should enact statutes tightening
the requirements that must be met before a foster child can be pre-
scribed psychotropic drugs, and allowing the courts (as opposed to gov-
ernment agencies) oversight concerning the final decision to medicate.
5. Jessenia Arias, Love Should Not Be Unaffordable, N.Y. TIMES (Oct. 29, 2012), http://
www.nytimes.com/roomfordebate/2012/10/29/should-the-adoption-tax-credit-be-renewed
/love-should-not-be-unaffordable.
6. Id.
7. Kendra Cherry, Psychoactive Drugs, ABOUT.COM, http://psychology.about.com/od
/psychoactivedrugs/tp/psychoactive-drugs.htm (last visited Nov. 3, 2013).
8. DANIEL NETTLE, PERSONALITY: WHAT MAKES YOU THE WAY YOU ARE 8 (Oxford Univ.
Press, 2007).
9. United States v. Charters, 829 F.2d 479, 489 (4th Cir. 1987).
10. Delilah Bruskas, Children in Foster Care: A Vulnerable Population at Risk, 21 J.
CHILD & ADOLESCENT PSYCHIATRIC NURSING 70 (2008).
11. Larry Cunningham, A Question of Capacity: Towards a Comprehensive and Consis-
tent Vision of Children and Their Status Under Law, 10 U.C. DAVIS J. JUV. L. & POL’Y 275,
317 (2006).
12. Eva J. Klain, Improving Oversight of Psychotropic Medication Use with Children
in Foster Care, 31 CHILD L. PRAC. 109 (2012).
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Once these requirements are met, the court should appoint an inde-
pendent attorney to zealously represent the interests of a foster child
at the hearing that decides whether to place the foster child on a psy-
chotropic drug regime.
I. PSYCHOTROPIC DRUGS AND FOSTER CHILDREN
It is necessary to define and examine the nature of psychotropic
drugs before discussing the legal policies. Psychotropic drugs are sub-
stances that change the brain chemistry which in turn changes mood
and behavior.13 These substances do this by passing through the blood-
brain barrier which “is composed of . . . specialized cells.”14 The cells
of the blood-brain barrier act as a selective barrier which only allows
certain chemicals and molecules to pass through and reach the brain.15
This selective barrier protects the brain chemistry and cognition by
blocking many chemicals and medicines that could effect the physi-
cal structure of the brain, brain chemistry, and as a result protects
cognition.16 Any molecule, or medicine that can cross the blood-brain
barrier can effect the chemistry of the brain which can cause psycho-
tropic (“mind altering”) side-effects.17 Some of the more serious effects
mind altering substances can have on the mind include: “[d]elirium,
mood changes, and psychotic symptoms.”18 Psychotropic drugs can
pass the blood-brain barrier which allows these substances to affect
the brain.19 In consequence, these substances can cause changes in
behavior, mood, consciousness, and overall cognition.20
Psychotropic substances have been used throughout history.21 For
example, people have in the ancient world, and up to present day,
13. Enjoli Francis, Psychotropic Drugs: What Are They?, ABC NEWS BLOG, (Dec. 2,
2011, 5:04 PM), http://abcnews.go.com/blogs/health/2011/12/02/what-you-need-to-know
-about-psychotropic-drugs/.
14. Abhilash K. Desai, Psychotropic Side Effects of Commonly Prescribed Medications
in the Elderly, PSYCHIATRY WKLY., http://www.psychweekly.com/aspx/article/ArticleDetail
.aspx?articleid=56 (last visited Nov. 3, 2013); Krishna Ramanujan, Breaching the Blood-
Brain Barrier: Finding May Permit Drug Delivery to the Brain for Alzheimer’s, Multiple
Sclerosis and Brain Cancers, SCIENCE DAILY (Sept. 14, 2011), http://www.sciencedaily.com
/releases/2011/09/110913172631.htm.
15. Ramanujan, supra note 14.
16. Id.
17. Desai, supra note 14.
18. Id.
19. Id.
20. Cherry, supra note 7.
21. Jonathan Wynne-Jones, Stone Age Man Took Drugs, Say Scientists, TELEGRAPH
(Oct. 19, 2008), http://www.telegraph.co.uk/news/newstopics/howaboutthat/3225729/Stone
-Age-man-took-drugs-say-scientists.html.
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partaken in alcohol, a psychotropic drug.22 These substances can occur
in nature and can be isolated, which allows for greater potency by in-
creasing the concentration of the active psychotropic chemical, or they
can be synthesized in a laboratory.23 There are different types of psy-
chotropic drugs, including depressants, stimulants, and hallucino-
gens.24 These drugs can be used to treat a variety of different mental
and personality disorders and are widely used as medicine.25 Psycho-
tropic drugs also have physical effects.26 Their very nature changes
the chemistry of the brain, which is a physical effect. These substances
can also affect other parts of the body.27 Some of these substances are
extremely powerful and cause complex biochemical reactions in the
body.28 These biochemical reactions are not isolated to the brain; they
also occur in other areas of the body.29 One reason that dosage must
be taken into account is due to these physical effects.30 A person can
die or have a serious physical injury if an incorrect dosage is given to
them.31 Dosage requirements change when there is a change in body
weight or mass.32 For example, if you have five milligrams of a sub-
stance and this dosage is given to a 200 pound person and a 120
pound person, the substances will be more diluted in the former and
cause less of an effect than in the latter.33 Thus, the dosage required
for an adult will be greater than the dosage required for a child.34
A. Effect of Psychotropic Drugs on the Mind of a Child
The effects of psychotropic drugs on the mind of a child are not
known. Currently, the research on psychotropic medicine lacks the
ability to inform doctors on the safe and suitable use of these drugs
22. David J. Hanson, History of Alcohol and Drinking around the World, ALCOHOL:
PROBLEMS AND SOLUTIONS, http://www2.potsdam.edu/hansondj/Controversies/1114796842
.html (last visited Nov. 3, 2013); Cherry, supra note 7.
23. See Coca & Poppy: Nature’s Addictive Plants, DEA MUSEUM, http://www.deamu
seum.org/ccp/coca/production-distribution.html (last visited Nov. 3, 2013).
24. Cherry, supra note 7.
25. Psychoactive Drugs, THE BODY, http://www.thebody.com/content/art4989.html (last
visited Nov. 3, 2013).
26. Francis, supra note 13.
27. Id.
28. Id.
29. Id.
30. Timothy S. Lesar, Prescribing Errors Involving Medication Dosage Forms, 7 J. GEN.
INTERN. MED. 579, 581 (2002).
31. Id.
32. Id. at 579.
33. Id.
34. Id.
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for pediatric patients.35 Alarmingly, there is very little evidence con-
cerning whether “pharmacologic interventions for the treatment of
trauma-related symptoms in children” is or is not effective.36 Without
suitable research, doctors and medical personnel do not currently have
accurate information concerning the short- and long-term effects of
psychotropic medicine on the minds and bodies of children, or on child
development.37 Although all of the short- and long-term effects are not
known, many children use psychoactive substances to control symp-
toms of ADHD, ADD, autism, bipolar disorder, and other disorders.38
For example, Methylphenidate (Ritalin) in particular is used to treat
autism and ADHD.39 Children may experience nervousness, palpita-
tions, increased heart rate, and psychosis due to taking Ritalin.40 The
Food and Drug Administration has linked certain psychotropic drugs
(antidepressants) to suicidal thoughts and behaviors in children.41
The case of Christopher Pittman is a powerful example of the
sometimes unusual and unpredictable effects psychotropic drugs can
have on young minds.42 In this case a psychiatrist testified in court
that he believed the psychotropic drug Zoloft could have led young
Pittman (twelve at the time) to kill both of his grandparents.43 Pittman
was a troubled child: he had a strained relationship with his father,
tried to run away from home and threatened to hurt himself with a
knife.44 After this incident he was prescribed the antidepressant Paxil,
and he went to live with his grandparents.45
35. ADMIN. FOR CHILDREN & FAMILIES, U.S. DEPT. HEALTH & HUMAN SERVS., INFORMA-
TION MEMORANDUM: PROMOTING THE SAFE, APPROPRIATE, AND EFFECTIVE USE OF PSYCHO-
TROPIC MEDICATION FOR CHILDREN IN FOSTER CARE 7 (2012), (citing Peter S. Jensen, et al.,
38 Psychoactive Medication Prescribing Practices for U.S. Children: Gaps Between Research
and Clinical Practice, J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY, 557 (1999)), avail-
able at http://www.acf.hhs.gov/sites/default/files/cb/im1203.pdf.
36. Id. (citing Holly R. Wethington, et al., The Effectiveness of Interventions to Reduce
Psychological Harm from Traumatic Events Among Children and Adolescents: A Systematic
Review, 35 AM. J. PREVENTATIVE MED., 287 (2008)).
37. Id. at 7–8.
38. M. Lynn Crismon & Tami Argo, The Use of Psychotropic Medication for Children
in Foster Care, 88 CHILD WELFARE 72 (2009).
39. Norra MacReady, Methylphenidate May Reduce ADHD Symptoms in Autism,
MEDSCAPE (May 24, 2011), http://www.medscape.com/viewarticle/743287.
40. Eni Williams, Ritalin Side Effects Center, RXLIST, http://www.rxlist.com/ritalin
-side-effects-drug-center.htm (last visited Nov. 3, 2013).
41. Laurel K. Leslie et al., The Food and Drug Administration’s Deliberations on Anti-
depressant Use in Pediatric Patients, 116 PEDIATRICS 195 (2005); Tori DeAngelis, Should
Our Children Be Taking Psychotropics?, 35 AM. PSYCHOLOGICAL ASSOC. 42, available at
http://www.apa.org/monitor/dec04/psychotropics.aspx.
42. Jim Polk, Defense Doctor: Zoloft Could Have Led Youth to Kill, CNN (Feb. 4, 2005),
http://www.cnn.com/2005/LAW/02/04/zoloft.trial/.
43. Id.
44. State v. Pittman, 647 S.E.2d 144, 152 (2007).
45. Id.
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While Pittman was living with his grandparents, his new doctor
did not have Paxil, so he abruptly changed the prescription to Zoloft.46
The family stated that after the change in medication Pittman began
to experience negative side effects and act out of character; his sister
stated that “he just acted like a crazy man.”47 Zoloft can have serious
side effects and can cause changes in behavior.48 After Pittman was
prescribed a high dosage of Zoloft he got into trouble at school and
church.49 His grandfather punished him and after his punishment,
Christopher Pittman shot both of his grandparents with a shotgun
and set the home on fire.50 Pittman’s father stated that he believed
Zoloft was the cause of the murders.51 Pittman’s defense attorney
opined that the drug turned off Pittman’s inhibitions, and allowed him
to act violently.52
Because the effects of psychotropic drugs on the minds of chil-
dren are not known, they should be prescribed with caution. Overpre-
scribing psychotropic drugs to foster children is a significant problem
because currently the effects of these drugs on the minds of young
children is unknown.53 We do not know what effects these drugs will
have on these children as they grow and develop. The adult mind is
different than the child’s mind because the adult mind has already
developed.54 The child’s mind, in contrast, is developing complex neu-
ral pathways and thus has different needs than the adult mind.55
Given the differences between child and adult minds, we do not know
whether these psychotropic drugs could adversely affect the continu-
ing development of a child’s brain. These potential adverse effects
should push us to closely scrutinize the prescription of drugs to foster
children, for their safety and healthy mental development.
B. Foster Children as a Vulnerable Group
Foster children are a vulnerable group in our society.56 These chil-
dren have been neglected by the people who were supposed to love
46. Id.
47. Rebecca Leung, Prescription For Murder?, CBS NEWS (Feb. 11, 2009), http://www
.cbsnews.com/8301-18559_162-687855.html.
48. Zoloft, PFIZER, http://www.zoloft.com/ (last visited Nov. 3, 2013).
49. Pittman, 647 S.E.2d at 152.
50. Id.
51. Leung, supra note 47.
52. Id.
53. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 7–8.
54. Nicole Giese, Adult and Child Brains Perform Tasks Differently, WASH. UNIV.
(May 11, 2005), http://news.wustl.edu/news/Pages/5295.aspx.
55. Id.
56. Bruskas, supra note 10.
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them the most, their parents, and some have been physically abused.57
This puts these children at an increased vulnerability to mental health
risks.58 Many children in foster care also have “poor developmental,
mental, and educational outcomes.” 59 Many of these children will have
difficulties transitioning from “foster care to young adulthood,” and
some “will succumb to poor choices that will prevent them from obtain-
ing” their greatest potential in life.60 The child welfare system and
society marginalizes and creates in foster children a feeling of power-
lessness.61 By not having a sense of control in which home they are
placed in, foster children are instilled with feelings of powerlessness.62
These psychological issues cause increased mental and emotional vul-
nerability in foster children.63
Also, the unstable environment caused by constant moving from
different foster homes causes there to be an absence of a strong adult
voice in the lives of foster children.64 The vulnerability makes the
overprescription of psychotropic drugs all the more troubling and prob-
lematic. These children are very vulnerable, they already have a pro-
pensity to have emotional difficulties, and often do not have a strong
adult that is looking out for their interests.65
C. Overprescription of Psychotropic Drugs for Foster Children
Foster children on average are prescribed more psychotropic med-
ications than other children. There are studies which consistently
show higher rates of psychotropic drug use and prescription in foster
children than in the general population; the range of “usage rates be-
tween [thirteen] and [fifty-two] percent.”66 This is a troubling development
57. Id.
58. Id.
59. Id.
60. Id.
61. Bruskas, supra note 10, at 74.
62. Id.
63. Id. at 72.
64. Id. at 70.
65. Id.
66. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 2, 3 (citing S. dosReis et al.,
Mental Health Services for Foster Care and Disabled Youth, 91 AM. J. PUB. HEALTH 1094
(2001)); JC McMillen et al., A Crisis of Credibility: Professionals’ Concerns about the Psychi-
atric Care Provided to Clients of the Child Welfare System, 34 ADMIN. & POL’Y IN MENTAL
HEALTH & MENTAL HEALTH SERV. RES. 203 (2007); OFFICE OF THE TEX. COMPTROLLER,
TEXAS HEALTH CARE CLAIMS STUDY: SPECIAL REPORT ON FOSTER CHILDREN (2007); M.
Olfson et al., National Trends in the Use of Psychotropic Medications by Children, 41 J. AM.
CHILD AND ADOLESCENT PSYCHIATRY 514 (2002); LK Leslie et al., Rates of Psychotropic
Medication Use over Time Among Youth in Child Welfare/Child Protective Services, 20 J.
OF CHILD & ADOLESCENT PSYCHOPHARMACOLOGY 135 (2010); B. T. Zima et al., Quality of
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for foster children. Psychotropic medication may be necessary for
foster children due to their maltreatment and higher rates of abuse
and neglect. However, “current use of psychotropic medications among
children in foster care . . . may exceed practice standards that are sup-
ported by empirical research.” 67
Foster children are more likely to be prescribed psychotropic
drugs, and are also more likely to be prescribed multiple psychotropic
drugs at “doses that exceed the maximum FDA approved levels.”68
One child, Ke’onte Cook, stated that during his tenure in foster care
he was prescribed and taking five drugs at a time.69 He stated that the
drugs made him feel irritable and exhausted, and lose his appetite.70
Since being adopted (and thus out of the foster care system) he is no
longer on any of those medications.71 Reflecting on his situation, Cook
states that he was “upset about [his] situation, not bipolar or ADHD,”
and that, “putting [him] on all of these stupid meds was the most idi-
otic thing [he] experienced in foster care, and the worst thing someone
could do to foster kids.” 72
As explained above, psychotropic drugs have unclear short- and
long-term effects on children.73 Also, as explained in a previous section,
foster children are a vulnerable group, with no strong parental or
guardian voice to completely look after their interests.74 These three
factors combined: 1) the unclear effects of psychotropic drugs on the
mind of a child, 2) the vulnerability of foster children, and 3) the over-
prescription of psychotropic drugs in foster children, support the idea
that heightened laws, regulations, and standards are needed regard-
ing the prescription of psychotropic drugs to foster children.
Publicly-Funded Outpatient Specialty Mental Health Care for Common Childhood Psychi-
atric Disorders in California, 44 J. AM. ACAD. CHILD ADOLESCENT PSYCHIATRY 130 (2005);
D.G. Ferguson et al., Psychotropic Drug Use with European American and American
Indian Children in Foster Care, 16 J. OF CHILD & ADOLESCENT PSYCHOPHARMACOLOGY,
474 (2006).
67. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 11.
68. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-12-270T, FOSTER CHILDREN HHS GUID-
ANCE COULD HELP STATES IMPROVE OVERSIGHT OF PSYCHOTROPIC PRESCRIPTIONS (2011)
(finding “the rate of children prescribed five or more psychotropic drugs concomitantly
ranged from 0.11 to 1.33 percent among foster children compared with 0.01 to 0.07 percent
rate among non-foster children.”), available at http://www.gao.gov/new.items/d12270t.pdf;
Jenny Gold, Foster Kids Given Psychiatric Drugs at Higher Rates, NPR (Dec. 1, 2011,
5:00 PM), http://www.npr.org/blogs/health/2011/12/01/143017520/foster-kids-even-infants
-more-likely-to-be-given-psychotropic-drugs.
69. Gold, supra note 68.
70. Id.
71. Id.
72. Id.
73. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 7–8.
74. Bruskas, supra note 10, at 70.
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II. CURRENT FEDERAL REGULATIONS AND STATUTES
Recent federal statutes require states that administer child pro-
tective services funded by the Social Security Act to address some
of the issues dealing with psychotropic drugs and the overprescrip-
tion of these drugs to foster children.75 The Fostering Connections to
Success and Increasing Adoptions Act of 2008 requires state child pro-
tective services to create plans for the oversight of foster children’s
health care services, including mental heath care.76
States with foster care programs must coordinate with health
care personnel for the health (including mental health) care needs of
foster children.77 The relevant clause of the Social Security Act, 42
U.S.C.A. § 622, states that the state must develop a plan to provide
“the oversight of prescription medicines, including protocols for the
appropriate use and monitoring of psychotropic medications” for chil-
dren in the state’s foster care program.78 In order for states to receive
funding from the federal government for running child protective ser-
vice programs, the states must create these plans to oversee psycho-
tropic medications and consult with physicians concerning children’s
mental health.79 This gives states considerable discretion to formulate
their own strategies and policies to effectively oversee and regulate the
prescription of psychotropic medications to foster children.
Some practice guidelines that the U.S. Department of Health and
Human Services have given are policies that allow for screening, as-
sessment, and treatment planning mechanisms to help the mental
health of foster children.80 The federal government has given the indi-
vidual states the ability to come up with their own plans concerning
the assessment and treatment of the mental health of foster children.81
Also, guidelines suggest that information concerning the treatment
of the child’s mental health should be given to all of the “key stake-
holders” in the child’s life.82 The agency also suggests that mental
health expertise is available “regarding both consent and monitoring
issues” during the child’s treatment.83 All of these suggestions are
merely guidelines.84 The federal government says that there must be
75. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 1–2.
76. Id. at 1–2; Camp, supra note 3, at 374.
77. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 1–2; Camp, supra note 3,
at 374.
78. 42 U.S.C.A. § 622 (West 2011).
79. Id.
80. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 12.
81. Id. at 1.
82. Id. at 12.
83. Id. at 13.
84. Id. at 11–13.
206 WILLIAM & MARY JOURNAL OF WOMEN AND THE LAW                  [Vol. 20:197
oversight and protocols relating to psychotropic drugs, but leaves it up
to individual states to decide how their system will work.85
Due to the vast discretion and ability of states to create and tai-
lor their own programs, it is necessary to examine the measures
states are taking in this regard before we can discuss policy reforms
and changes.
A. Illustrative Examples of the Importance of State Regulations
and Statutes Regarding Psychotropic Drugs
Two New York cases illustrate the need for effective state regu-
lations regarding the prescription of psychotropic drugs. In the case
In re Lyle A., Lyle was neglected by his mother, and as a result he
(along with his siblings) went into foster care.86 Lyle had been sexu-
ally and physically abused by adults responsible for his care.87 When
he entered foster care he was emotionally unstable, “suffered from
ringworm, an infected ingrown toenail, and anemia.” 88 The child “had
been observed drinking out of [a] toilet, eating paper, and digging in
the garbage.” 89 He was subsequently sexually abused while in foster
care.90 Lyle then began to act out.91 He was moved around to a num-
ber of different foster homes, thus creating an unstable living envi-
ronment.92 Due to his emotional downward spiral, the caseworker
thought that the situation was life-threatening, and she put Lyle (a
four-and-a-half-year-old boy), on Depakote sprinkles.93
In another case involving Depakote sprinkles, In re Martin F.,
Desiree, a two-year-old child, and her brother were placed into foster
care.94 Desiree entered into foster care as a mentally and emotionally
healthy child, but began a downward spiral after entering into the
foster care program.95 Desiree was moved from four different foster
care homes within a five-month time frame.96 Desiree was physically
abused in her third foster home and allegedly in a prior foster home.97
Desiree’s behavior continued to get progressively worse.98 The foster
mother and the government caseworker decided it would be a good
85. Id. at 2.
86. In re Lyle A., 830 N.Y.S.2d 486, 487 (N.Y. Fam. Ct. 2006).
87. Id. at 487.
88. Id.
89. Id.
90. Id. at 488.
91. Id.
92. In re Lyle A., 830 N.Y.S.2d at 488–89.
93. Id. at 489.
94. In re Martin F., 820 N.Y.S.2d 759, 764 (N.Y. Fam. Ct. 2006).
95. Id.
96. Id.
97. Id.
98. Id. at 765.
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idea (over the objections of the mother) to put the then three-year-old
child on Depakote sprinkles.99
Depakote is a power psychotropic drug used to treat seizure dis-
orders, mental disorders, emotional disorders, and migraines.100 Side
effects include diarrhea, dizziness, drowsiness, hair loss, vision dam-
age, ringing in the ears, shakiness, unsteadiness, weight changes,
depression, suicidal thoughts, and in some rare cases a severe and
sometimes fatal brain disorder, serious (sometimes fatal) liver prob-
lems, pancreas problems, and birth defects.101 Children that are two
years old and younger “are more likely to develop severe liver prob-
lems” when taking Depakote sprinkles.102 Due to the plethora of
potential serious side effects, this type of drug clearly should only be
used when a child absolutely needs it. The children in the two prior
cases did not need this type of powerful, and sometimes fatal, drug.103
These children needed what every child needs: love, tenderness, stabil-
ity, and no physical abuse. The fact that the state decided that these
children needed this powerful psychotropic drug that can cause a host
of physical and mental issues shows that the standards for prescribing
these drugs are not nearly high enough.
Lyle and Desiree were both taken off of the psychotropic drug reg-
imen. However, not every child is so fortunate; these drugs are fatal
in some cases.104 Rebecca Riley was a four-year-old girl who was diag-
nosed with ADHD and bipolar disorder.105 Once diagnosed, she was
given “Clonidine, a blood pressure medication . . . prescribed for
ADHD; Depakote, an antiseizure and mood-stabilizing drug prescribed
for the little girl’s bipolar disorder; a cough suppressant; and an anti-
histamine.”106 This drug cocktail proved fatal, and Rebecca died.107
As stated in previous sections, and illustrated in the two cases
above, contributing causes of this problem include the following:
the vulnerability of foster children, and their lack of a strong par-
ental, guardian, or frankly any voice to completely look after their
interests.108
99. Id. at 766–67.
100. Drugs & Medications—Depakote Sprinkles Oral, WEBMD, http://www.webmd.com
/drugs/drug-9118-Depakote+Sprinkles+Oral.aspx?drugid=9118&drugname=Depakote
+Sprinkles+Oral (last visited Nov. 3, 2013).
101. Id.
102. Id.
103. Camp, supra note 3, at 376.
104. Id.
105. Girl’s Death Stirs Debate over Psychiatric Meds, NBC NEWS (Mar. 23, 2007,
4:11 PM), http://www.msnbc.msn.com/id/17758170/ns/health-childrens_health/t/girls-death
-stirs-debate-over-psychiatric-meds/#.UPcyC6W5fzI.
106. Id.
107. Id.
108. Bruskas, supra note 10, at 70.
208 WILLIAM & MARY JOURNAL OF WOMEN AND THE LAW                  [Vol. 20:197
B. Current State Regulations and Statutes
Many states have ignored the current issue of overprescription of
psychotropic drugs to foster children.109 States that continue to ignore
this issue do so at the peril of the children under their care.110 Foster
children deserve more from the state and our society than compla-
cency and neglect.111 Some states, however, have begun to address this
issue. Some states use consent procedures for prescribing psychotropic
medicine to children in their foster care program.112
In New York, the court stated in Martin that a natural parent has
the right to make decisions concerning the medication of their child in
foster care.113 The parent can refuse psychotropic medication on behalf
of the foster child.114 Consent obtained must be informed, thus the doc-
tor must speak to the foster child’s parent personally.115 However, “if
a physician believes that a parent’s decision is not what a child/patient
if competent would have decided, and could not reasonably be judged
to be within the child/patient’s best interests, then a court order to ad-
minister medication should be requested.”116
Therefore, it is possible under the New York law that a court may
issue an order authorizing a child to be prescribed psychotropic drugs
without the parent’s informed consent.117 In the state of New York, in-
formed consent includes information about potential side-effects and
the danger of the drug.118 It also includes the potential benefits of the
drug and how likely it is that it will work.119 A few other states (includ-
ing Florida, California, Illinois, Oregon, Connecticut, and Tennessee)
use consent procedures for prescribing psychotropic medicine to
children in their foster care programs similar to the New York con-
sent process.120
The consent process is a good starting point for protecting the
child, but there is still work to be done.121 In New York, both Lyle and
Martin were decided while New York had the consent process.122 In
109. Camp, supra note 3, at 373.
110. Id. at 369.
111. Id. at 404.
112. Id. at 397.
113. In re Lyle A., 830 N.Y.S.2d 486, 492 (N.Y. Fam. Ct. 2006).
114. Id.
115. Id.
116. Id.
117. Id.
118. Id.
119. In re Lyle A., 830 N.Y.S.2d at 492.
120. Camp, supra note 3, at 397.
121. Id. at 399–400.
122. In re Lyle A., 830 N.Y.S.2d at 492; In re Martin F., 820 N.Y.S.2d 759, 768–69
(N.Y. Fam. Ct. 2006).
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both cases, the natural parents had to go to court to end treatment
of their children; the state-run child foster agency did not respect
their interests.123
Likewise, in Florida, “a 2006 internal study . . . found that, despite
the foregoing safeguards, approximately one in six children receiving
psychotropic medications received their prescriptions without the le-
gally required consent.”124 This shows that although these policies are
a good start, they are missing key components.
One of the main problems with the consent standards states have
enacted is that the natural parents of foster children are either vulner-
able people themselves, neglectful, or abusive.125 It is difficult to un-
derstand how a natural parent’s consent will help a foster child when
that same parent cannot or will not care for the child due to issues out-
side of his or her concern. Some authors have argued for, and some
states have made reforms which necessitate, a natural parent’s con-
sent before the state prescribes psychotropic drugs. This reform is
meant to give foster children extra protection.126 Some of these states
(Florida and Tennessee) include the natural parent in the consent
process.127 While the motive behind this policy is well-intentioned, it
does not appear that this is an effective policy.
Natural parents of children with foster care are either vulnerable
people themselves (very poor, or people with addiction or other prob-
lems), neglectful, or abusive.128 These people are usually not the best
people to be their child’s advocate. Some natural parents do not fully
understand the effects of this medication on their children.129 Also, be-
cause these parents are either in a vulnerable position themselves, or
abusive,130 more educated government officials could have a greater
influence on the decision to medicate the foster child.
As noted above, it is unclear how obtaining these people’s consent
will help protect the child’s legal rights. The reason the child is in fos-
ter care (and many times the reason the child has emotional problems)
is attributable to the actions by their natural parents—the very people
from whom the states are seeking consent.131 Also, the state doctors
and officials usually know much more about the issues than these
123. In re Lyle A., 830 N.Y.S.2d at 493; In re Martin F., 820 N.Y.S.2d at 760–61.
124. Camp, supra note 3, at 400.
125. See supra notes 58–61 and accompanying text.
126. Camp, supra note 3, at 392.
127. Id. at 397–99.
128. Sandra Bass et al., Children, Families, and Foster Care: Analysis and Recommenda-
tions, 14 THE FUTURE OF CHILDREN 6, 4 (2004).
129. See, e.g., In re Lyle A., 830 N.Y.S.2d 486, 498–91 (N.Y. Fam. Ct. 2006).
130. See Camp, supra note 3, at 390.
131. See supra notes 56–58 and accompanying text.
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parents, which can create an unequal balance of power.132 Even though
the parents must be fully informed under New York law, they still
may feel intimidated and defer to the state officials and thus not pro-
tect their natural child’s legal rights.133 The consent process may pro-
tect the parental rights of the natural parent, but due to the above
reasons, will likely not protect the child’s rights and best interest.
In most cases, including a foster child’s natural parent in the pro-
ceeding will not create an independent voice that is purely for the
child’s best interest. The vulnerability of foster children and their nat-
ural parents calls the current standards that are being used into ques-
tion and pushes us to heighten the current standards.
In the following sections, this Note will discuss ways to remedy
the issues discussed above, and to give foster children more protection
regarding psychotropic drugs.
C. Constitutional Issues with the Prescription of Psychotropic Drugs
One of the issues created by state agencies determining whether
children can be medicated is the constitutional right of freedom of
thought.134 If a person that is in the state’s care or custody has the
competency required to consent to or refuse medical care, his constitu-
tional interests in making such a choice must be taken into account.135
If a person has the capacity to consent, his interest in freedom of
thought outweighs the government’s interests.136 A patient is pre-
sumed competent unless a court finds otherwise. However, children
who have not yet reached the age of capacity do not have the re-
quired capacity or competency needed to make medical decisions.137
A patient’s lack of capacity does not extinguish the patient’s constitu-
tional rights.138 If a person lacks capacity then the custodians must
obtain a court order before a psychotropic medication regimen can
begin.139 Under circumstances of inadequate capacity, the court must
132. Camp, supra note 3, at 390.
133. See, e.g., In re Lyle A., 830 N.Y.S.2d at 489–90.
134. United States v. Charters, 829 F.2d 479, 489–90 (4th Cir. 1987), aff’d on reh’g, 863
F.2d 302 (4th Cir. 1988).
135. Id. at 484.
136. Id.
137. Id.; Larry Cunningham, A Question of Capacity: Towards a Comprehensive and
Consistent Vision of Children and Their Status Under Law, 10 U.C. DAVIS J. JUV. L. &
POL’Y 275, 317, 324 (2006) (stating minors are “categorically incapable of giving informed
consent for most medical procedures” subject to the mature minor doctrine. In some states
a court will allow a minor to make decisions concerning medical procedures if the court de-
termines that the child can comprehend the nature of the treatment. Many states also
require the minor to be close to the age of majority in order to apply this exception.).
138. Charters, 829 F.2d at 484.
139. Id.
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determine what treatment the person would select for himself and
whether the person would select the treatment if the person were
competent and could choose his own medication or choose not to
medicate.140
Under circumstances of inadequate capacity, the court must also
take into consideration the physical and mental effects these drugs
may have.141 The Supreme Court has found that psychotropic drugs
“may well cause serious and irreversible injury in a significant per-
centage of cases.”142 Psychotropic medications may not only cause
serious injury to a person, but could also infringe on the person’s con-
stitutional right to freedom of thought.143 In the eyes of the Fourth
Circuit there is no difference between “the chemical invasion of drug
therapy and the mechanical invasion of surgery” in determining
whether there was a freedom of thought violation.144 Psychotropic
drugs can affect mood, thought processes, and personality which are
the core of what makes an individual an individual.145
With these constitutional issues in mind, there are some in-
stances where the needs of the community outweigh the needs of the
individual.146 In cases where a court determines that physical harm
or violence could result from a lack of medication, or if deterioration
of the patient’s health could result from the lack of medication, the
interests of the community may override the interests of the patient.147
However, with small children it is hard to imagine a situation where
a child would be so violent to the community that this would come into
play; their physical size is such that it is unlikely that they could
cause much damage to the community. Psychotropic medications can
be used effectively as treatment, but one of the reasons they are used
is to control behavior, to discipline, and as a result they have occasion-
ally been misused.148 People should be informed of their potential side
effects and potential adverse effects of the psychotropic medication
that the state is attempting to prescribe them.149
140. Id.
141. Id. at 489.
142. Id. (citing Bee v. Greaves, 744 F.2d 1387, 1396 (10th Cir. 1984)); Rennie v. Klein,
720 F.2d 266, 276 (3d Cir. 1983); Matter of Guardianship of Roe, 421 N.E.2d 40, 52
(Mass. 1981).
143. Charters, 829 F.2d at 489–90.
144. Id. at 489.
145. Id.
146. Id. at 493–94.
147. Id.
148. Matter of Guardianship of Roe, 421 N.E.2d 40, 53 (Mass. 1981).
149. Id. (quoting Robert Plotkin, Limiting the Therapeutic Orgy: Mental Patients’ Right
to Refuse Treatment, 72 NW. U.L. REV. 461, 466–74 (1977)).
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Modern science tells us that the brain is plastic and is shaped by
our experiences.150 Modern science also tells us that experiences, ideas,
and our personalities are stored by the neural pathways that our ex-
perience and thoughts create and build throughout our lives.151 The
long- and short-term effects of psychotropic medication on the minds
of children are presently unknown. However, there is a fear that psy-
chotropic medication could be disruptive to the development of neural
pathways.152 Such a scenario would cause the person to not be able to
fully exercise the freedom of thought, individuality, and the right to
have an individual personality.153
With the constitutional right of freedom of thought at stake, it is
important for foster children to have heightened protection against
psychotropic drug regimens, especially since the child could have his
or her constitutional right to freedom of thought curtailed by the ad-
verse effects of psychotropic medication.
III. PROPOSED HEIGHTENED STANDARD
As shown above, the overprescription of psychotropic drugs is a
big problem for foster children.154 The federal government and the
states have (as shown in the previous section) heightened standards
in recent years.155 These heightened standards are not enough.156
A. Independent Counsel
Some states have listened to the federal government’s recommen-
dations and have heightened standards that have a parental consent
requirement concerning the prescription of psychotropic drugs.157 How-
ever, it is difficult to understand how a parent’s consent will help a fos-
ter child when that same parent cannot or will not care for the child
(due to issues under their control or issues out of their control).158 The
federal government should recommend, and individual states should
150. Sharon Begley, The Brain: How the Brain Rewires Itself, TIME (Jan. 19, 2007),
http://www.time.com/time/magazine/article/0,9171,1580438-1,00.html.
151. Id.
152. ADMIN. FOR CHILDREN & FAMILIES, supra note 35, at 7–8; James Morris & George
Stone, Children & Psychotropic Medication: A Cautionary Note, 37 J. MARITAL & FAMILY
THERAPY 299, 302 (2011).
153. United States v. Charters, 829 F.2d 479, 489, 492 (4th Cir. 1987).
154. Camp, supra note 3, at 373.
155. Id. at 374.
156. Id. at 374–75.
157. Id. at 374; see also In re Lyle A., 830 N.Y.S.2d 486, 494–96 (N.Y. Fam. Ct. 2006).
158. Bruskas, supra note 10, at 70.
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enact, statutes requiring that an independent advocate be appointed
to zealously represent the interests of a foster child.
Foster children are some of the most vulnerable groups in our
society and they need an advocate to look after their interests.159 An
independent advocate for the foster child would be a powerful voice for
the interest of the child. This advocate would be available to consult
with the foster child’s natural parent, help make sure the natural
parent’s constitutional and statutory parental rights were protected,
and make sure the child’s constitutional and statutory rights were pro-
tected. The advocate would have the power to review the child’s med-
ical files, call independent medical experts, review the files of the
caseworkers, and be familiar with the child’s overall history. This
would give the advocate insight into the world of the foster child and
help the advocate represent the child and petition the court for the
best options for the child.
The court-appointed independent advocate would protect foster
children’s freedom of thought. The advocate would completely repre-
sent foster children in cases where they do not have the capacity to be
adequately informed of the potential adverse effects of the medication
and do not have the capacity to consent. This would further protect the
children’s rights to freedom of thought. When the court is petitioned
to begin psychotropic medication, the independent advocate would be
there to represent the child’s rights in court.
Long-term health and wellness is what is at stake in these cases,
and therefore children who do not have capacity and do not have a
strong parental voice in their life should have an independent coun-
sel to protect their rights and advocate on their behalf. In cases
where a child may be prescribed psychotropic drugs, the child’s free-
dom of thought, and potentially freedom of individuality, hangs in
the balance.160
One state is already appointing independent advocates to rep-
resent children in court: Oregon.161 Oregon law requires that a court
must inform the child’s special advocate of the psychotropic drug
medication.162 The special advocate may petition the court to dis-
continue the medication if the advocate objects to the medication.163
The special advocate in Oregon is a member of the CASA Volunteer
Program.164 These volunteers are court appointed, and they advocate
159. Id.
160. United States v. Charters, 829 F.2d 479, 490 (4th Cir. 1987).
161. OR. REV. STAT. § 418.517 (West 2012).
162. Id.
163. Id.
164. OR. REV. STAT. § 419A.004 (West 2012).
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for Oregon’s foster children.165 These volunteers give children a voice
that keeps them from getting “lost in the overburdened legal and so-
cial service system.”166 The same court-appointed volunteers stay with
each child throughout the foster care process until “the child is placed
in a safe, permanent home.”167 This court-appointed volunteer is a con-
stant adult presence, which is important because this is lacking in so
many foster children’s lives.168 Research demonstrates that children
fare better with these independent advocates than without them.169
The experience with independent advocates shows that they help
children in the foster child system.170 Use of these advocates is the
right step forward in protecting children’s rights and protecting them
from the inappropriate prescription of psychotropic drugs.
B. Heightened Judicial Standard
The second prong to the proposed new standard is a heightened
judicial standard in putting children on a psychotropic medication re-
gime. In many cases, the FDA has not adequately tested psychotropic
drugs regarding children, and has not determined the long and short
term effects on the minds and mental development of children.171 This
is due to the ethical difficulties in acquiring and using children as
medical test subjects for psychotropic drugs and other drugs.172
Physicians prescribe psychotropic drugs to children, but due to
the lack of FDA approval, physicians must prescribe these drugs “off-
label” in instances where there is not adequate testing or data on the
effects of the drug, and the child needs the medication.173 Many of the
newer psychotropic medications are prescribed to children off-label
because there has not been adequate testing in children regarding
the safety and the efficiency of these newer psychotropic drugs in chil-
dren, and there is little knowledge on the long- and short-term effects
on children.174 Off-label usage of many medications in children is
necessary because of the lack of FDA testing, and the use of such is
common.175 This is because most drugs have not, and are not, able to
be studied adequately in children as stated above.176
165. About Us, CASA FOR CHILDREN, http://www.casaforchildren.org/site/c.mtJSJ7MPI
sE/b.5301303/k.6FB1/About_Us__CASA_for_Children.htm (last visited Nov. 3, 2013).
166. Id.
167. Id.
168. Id.
169. Id.
170. Id.
171. Morris & Stone, supra note 152, at 302.
172. Camp, supra note 3, at 379 n.82.
173. Id. at 379.
174. Id. at 379; Leslie et al., supra note 41, at 196.
175. Leslie et al., supra note 41, at 196.
176. Morris & Stone, supra note 152, at 301–02.
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Because the FDA has not adequately tested certain psychotropic
drugs, the court or legislature should create a new judicial standard
of review where psychotropic drugs are only given to foster children
when necessary for the well-being of the child. Policy reasons for this
include the protection of vulnerable foster children.177
The knowledge that foster children are vulnerable, and are dis-
proportionately given psychotropic drugs compared to the rest of the
population178 speaks to the need of greater judicial scrutiny. Granted,
the average foster child has had a more difficult life than an average
child not in the foster program, and thus it is more likely that foster
children are more susceptible to mental illness.179
This point aside, it is important for our society that foster children
learn to become productive citizens. It is more difficult for someone to
become a productive citizen if they are medicated for their entire child-
hood and their development is interfered with by psychotropic drugs.
These drugs most likely negatively impact development.180
Courts have held that without consent, the court must conduct a
best interest inquiry when doctors wish to administer these types of
drugs to non-consenting mentally ill patients.181 Some of the same pol-
icy reasons that apply to foster children also apply to the mentally ill:
they are vulnerable, and unable to give consent.182 Like mentally ill
people, foster children also need judicial protection. The similar vul-
nerabilities and inability to consent should prompt state legislatures
and courts to heighten the standards relating to the prescription of
these psychotropic medication to foster children.
Due to these reasons, a strict judicial test should be enacted stat-
ing that unless psychotropic drug use is necessary for the well-being
of the child, the drugs should not be administered. The reason for a
judicial test and proceeding is that it is more fair to the constitutional
and statutory rights of the child and the child’s due process to estab-
lish a judicial proceeding as opposed to an administrative board.183
177. Camp, supra note 3, at 373. For a discussion on the vulnerability of foster children,
see Bruskas, supra note 10.
178. Id.; Bruskas, supra note 10, at 70.
179. Bruskas, supra note 10, at 70–71.
180. Morris & Stone, supra note 152, at 302.
181. Myers v. Alaska Psychiatric Inst., 138 P.3d 238, 250 (Alaska 2006); see also Jarvis
v. Levine, 418 N.W.2d 139, 147 (Minn. 1988); Steele v. Hamilton Cty. Cmty. Mental Health
Bd., 736 N.E.2d 10, 21 (Ohio 2000).
182. The Vulnerability of Patients Suffering from Mental Illness as Research Subjects,
ONLINE ETHICS CENTER FOR ENG’R. (Sept. 11, 2006), http://www.onlineethics.org/Resources
/TeachingTools/Modules/19237/resethpages/vuln.aspx.
183. See Myers, 138 P.3d at 254 (holding that the Alaska constitution’s guarantees of lib-
erty and privacy make it necessary for a court to use a best interest test in ordering a psy-
chotropic drug regime if a patient cannot consent to the procedure).
216 WILLIAM & MARY JOURNAL OF WOMEN AND THE LAW                  [Vol. 20:197
A child and the child’s advocate would be able to appear in court
and in an adversarial proceeding be able to fully enforce the rights of
the child.184 A judge, independent of the agency, would be available to
oversee the medication when needed, or deny the medication when
deemed to be not necessary for the child.185 The judge would be able to
listen to the concerns raised by the independent counsel who could
fully inform the child’s natural relatives of their rights, and thus be
able to fully communicate and give voice to the desires of the natural
family when present, and the child.186 The judge would consider the
views of the child, and then listen to the views of the agency and of the
independent doctors and then make his or her decision.
By basing the standard on whether the medication is necessary,
the judge will be protecting the issues stated above that are causes for
concern. The judge will protect the child from potential adverse effects
of the medication unless it is necessary for the child to be medicated.187
This high standard is needed because so much is at stake: the child’s
mental, physical, and emotional health are on the line.
C. Accountability to the Public
Another reason for the judicial standard and for the guardian
ad litem is more accountability to the public. In some cases the gov-
ernment officials administering the foster program have allowed chil-
dren as young as three years old to be given powerful psychotropic
drugs.188 These administrative proceedings are often not as account-
able to the public because they are done by administrative and bu-
reaucratic boards.189
The courts on the other hand are more accountable to the pub-
lic, and thus provide a check on the bureaucracy.190 Although many
juvenile court cases are closed to the public, judges in many parts of
the country are visible figures in their communities as compared
to bureaucrats.
Judges are usually attuned to public feelings, and in some states
judges are elected.191 This greater judicial accountability to the public,
184. CASA FOR CHILDREN, supra note 165.
185. See Myers, 138 P.3d at 250.
186. Id.; CASA FOR CHILDREN, supra note 165.
187. Myers, 138 P.3d at 250 (“[B]efore a state may administer psychotropic drugs to a
non-consenting mentally ill patient in a non-emergency setting, an independent judicial
best interests determination is constitutionally necessary to ensure that the proposed treat-
ment is actually the least intrusive means of protecting the patient.”).
188. See, e.g., In re Martin F., 820 N.Y.S.2d 759, 767 (N.Y. Fam. Ct. 2006).
189. Thomas E. Patterson, The American Democracy, MCGRAW-HILL, available at http://
highered.mcgraw-hill.com/sites/0072481218/student_view0/chapter13/.
190. Id.
191. See, e.g., N.C. GEN. STAT. ANN. § 416 (West 2013).
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especially in states where judges are elected, makes judges much more
thoughtful in their decisions than the more anonymous bureaucrat.
This thoughtfulness will more adequately protect the rights of children
and their well-being.
Greater judicial accountability should incentivize judges to not
make decisions to medicate children unless such medication is neces-
sary. In many states, bureaucrats and administrative boards are
much less accountable and much less public than the courts.192
An increase in accountability to the public, judges’ desire to have
a positive legacy, and judges’ awareness of public standards are all
reasons why the judiciary is better fitted to determine whether foster
children will be medicated than bureaucrats.
CONCLUSION
The current epidemic of overprescription of psychotropic medica-
tion in foster children is an issue that states and the federal govern-
ment need to address.193 Foster children are a vulnerable group that
can be easily overlooked by our society and fall through the cracks.194
Foster children are a group in our society that lack parental guidance
and protection.195 In some cases these children have been neglected
and abused.196 Many of these children have increased vulnerability to
health and mental risks, and many have developmental issues.197
These children do not have a stable family life or a strong adult pres-
ence looking after their interests.198
Foster children are overprescribed psychotropic drugs, and these
drugs likely have negative long-term effects on these children.199 The
effects of psychotropic medication also call into question the constitu-
tional freedom of thought.200 Prescribing psychotropic medication to
people can affect their ability to freely think by altering brain chemis-
try and affecting the neural pathways which is just as intrusive as
“mechanical surgery.” 201
192. Patterson, supra note 189.
193. Camp, supra note 3, at 401.
194. See discussion infra Part I.B.
195. Id.; Bruskas, supra note 10, at 70.
196. Bruskas, supra note 10, at 70.
197. Id.
198. Id.
199. See discussion infra Part I.C; Camp, supra note 3, at 373; Morris & Stone, supra
note 152, at 302.
200. See discussion infra Part II.C; United States v. Charters, 829 F.2d 479, 489 (4th
Cir. 1987).
201. Charters, 829 F.2d at 489.
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One of the purposes of childhood is to learn to control one’s emo-
tions and learn to effectively work with others.202 If one is overmedi-
cated, one has a warped sense of reality and cannot effectively learn
to live with oneself, one’s emotions, and the effect others have on one’s
emotions.203 Therefore, it is a great disservice to put children on psy-
chotropic drugs when it is unnecessary due to the interference with
emotional and mental development.204
Not only is it a disservice due to the mental and emotional issues
as stated above, it is also a disservice due to the physical effects and
dependency that can arise as a result from psychotropic drug use.205
Many psychotropic drugs are very powerful and some have many ad-
verse physical and psychological effects.206
Due to the effects of psychotropic drugs on children physically and
emotionally, the constitutional question, and the vulnerability of the
foster children group as a whole, the federal government enacted new
laws and provided standards to protect foster children from psychotro-
pic drugs.207 Federal agencies have given the states the ability to come
up with their own plans concerning the assessment and treatment of
the mental health of foster children.208
Some states have ignored this issue, and some have opted for an
informed consent policy.209 The problems with ignoring this epidemic
are evident, and ignoring this issue will not solve anything. One of the
main problems with the informed consent standards that states have
enacted is that the natural parents of foster children are either vulner-
able people themselves, neglectful, or abusive.210 Therefore, the in-
formed consent standard, and the new federal mandate is not enough.
In order to adequately protect foster children from being overpre-
scribed psychotropic drugs when they are not needed there should be
a two pronged approach.
First, states should draft legislation to ensure its courts appoint
an independent advocate to represent the foster child’s interests.211
202. Robin Stern, Social and Emotional Learning: What Is It? How Can We Use It to
Help Our Children?, NYU CHILD STUDY CTR., http://www.aboutourkids.org/articles
/social_emotional_learning_what_it_how_can_we_use_it_help_our_children (last visited
Nov. 3, 2013).
203. Charters, 829 F.2d at 479 (recognizing that psychotropic drugs impede freedom
of thought).
204. Id.
205. Francis, supra note 13.
206. Morris & Stone, supra note 152, at 302.
207. ADMIN. FOR CHILDREN & FAMILIES, supra note 35.
208. Id.
209. See discussion infra Part II.B.
210. See supra notes 58–61 and accompanying text.
211. See discussion infra Part III.A.
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This will ensure that the rights of the child and the child’s well-being
are being protected.212 Oregon has recently passed a law to follow this
approach.213 The independent advocate would be able to look at the
child’s records, could inform the child’s natural family of their rights
and remedies, and be a strong voice completely looking after the child’s
best interest.214 The independent advocate would be a strong and
consistent adult presence in the life of the foster child.215 This is impor-
tant, as the presence of this advocate has been shown to help chil-
dren’s ability to navigate and eventually leave the foster system.216
The next prong is to make it necessary for a court to order the
medication only if necessary for the child’s health and well-being.217
These prongs will protect the child from psychotropic drugs unless
they are absolutely necessary.218
The overprescription of psychotropic drugs is a significant prob-
lem for foster children.219 As seen in some of the illustrative examples
and the science above, psychotropic drugs can harm and sometimes
prove fatal to children taking these prescriptions.220
The above steps will be a good start for states to begin to protect
the rights of foster children, and to help ensure that their voices will
be heard. These children need strong voices to protect them, stand up
for them and to ensure foster children have a voice in our society.
In other words, if the state follows these steps and passes laws
and regulations to protect the interest of foster children, the state, the
court, and the independent advocate will all be strong voices for a
vulnerable group.
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